Delivery Order SPE2DB22D3501-SPE2DB26FTK26
- Not listed
- The Defense Logistics Agency awarded a $8,547.16 delivery order to AmerisourceBergen Drug Corp for Prolia 60 mg/mL syringes, with an ultimate completion date of October 21, 2025. This non-competitive, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to the company's facility in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 15, 2025, for Prolia 60 mg/mL syringes valued at $12,957.22. The contract employs firm fixed pricing with an ultimate completion date of September 16, 2025, and was competitively awarded without set-aside designation. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $7,575.13 delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Prolia 60 mg/ml syringes. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The delivery is scheduled for completion by October 23, 2025, with performance taking place at...
- The Defense Logistics Agency awarded a delivery order valued at $9,615.87 to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringe supplies. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of October 17, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among qualified vendors in the open market. This delivery order is issued under...
- The Defense Logistics Agency awarded a $12,084.12 delivery order to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of June 3, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $15,697.68 to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of September 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,852.74 to AmerisourceBergen Drug Corp for the supply of Prolia 60 mg/ml syringes, with an ultimate completion date of September 19, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $61,057.84 delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Prolia 60 mg/ml syringes. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 11, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Prolia 60 mg/mL syringes, valued at $9,104.04 under firm fixed price terms. The award, issued on August 7, 2025, with completion targeted for August 8, 2025, represents a child delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $12,735.09 to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Prolia 60 mg/ml syringes. This is a firm fixed price, non-set-aside contract with a completion date of September 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a competitive award under the company's existing pharmaceutical supply framework with the federal government. This...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB26FTK26Delivery Order
The Defense Logistics Agency awarded a $8,571.60 delivery order to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of November 6, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. Prolia, a bone-building medication used to treat osteoporosis, supports the Defense Health Agency and other federal healthcare systems' pharmaceutical needs. AmerisourceBergen's consistent receipt of competitively awarded delivery orders demonstrates its established capability to fulfill federal medical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 11/5/25 |